Park H J, Park K M, Rhee M H, Song Y B, Choi K J, Lee J H, Kim S C, Park K H
Department of Biochemical Pharmacology, Korea Ginseng and Tobacco Research Institute, Taejon, Korea.
Biol Pharm Bull. 1996 Jun;19(6):834-8. doi: 10.1248/bpb.19.834.
We investigated the effects of ginsenoside Rb1 (G-Rb1), a major saponin from Panax ginseng C. A. MEYER, on rat liver protein phosphorylation after intraperitoneal administration of CCl4 alone or together with G-Rb1. We found that 118, 63, and 34kDa proteins were prominently phosphorylated in liver homogenates prepared from CCl4-administered rats, while these protein-phosphorylations were inhibited in the homogenate prepared from the G-Rb1 plus CCl4-administration group. When inhibitors of protein kinases were exogenously added to the homogenates from either the CCl4-administered group or the G-Rb1 plus CCl4-administered group, their phosphorylations were inhibited much more by W-7, an inhibitor of Ca2+/calmodulin-dependent protein kinase (CaM-PK), than by H-7, an inhibitor of protein kinase C (C-kinase). Interestingly, only 34kDa was phosphorylated in homogenates prepared from the corn oil-, G-Rb1-, and G-Rb1 plus CCl4-administered groups by the exogenous addition of sodium fluoride (NaF), an inhibitor of glycogen synthase. Additionally, G-Rb1 inhibited the Ca(2+)-accumulation induced by CCl4 both in liver homogenates and microsomes. The above results imply that G-Rb1 inhibits the CCl4-induced protein phosphorylations by modulating CaM-PK rather than C-kinase, and that 34kDa protein may play a different biological role in cellular environment from 118 and 63kDa proteins. Therefore, a study in which G-Rb1 is employed as a modulator of critical CCl4-induced phenomena ranging from the disturbance of Ca2+ concentration to protein phosphorylation may be successfully applicable to investigate the diverse physiological functions of liver.
我们研究了人参皂苷Rb1(G-Rb1),一种来自人参(Panax ginseng C. A. MEYER)的主要皂苷,对单独腹腔注射四氯化碳(CCl4)或与G-Rb1联合注射后大鼠肝脏蛋白质磷酸化的影响。我们发现,在由注射CCl4的大鼠制备的肝脏匀浆中,118、63和34 kDa的蛋白质显著磷酸化,而在由G-Rb1加CCl4注射组制备的匀浆中,这些蛋白质的磷酸化受到抑制。当将蛋白激酶抑制剂外源添加到注射CCl4组或G-Rb1加CCl4注射组的匀浆中时,与蛋白激酶C(C激酶)抑制剂H-7相比,Ca2+/钙调蛋白依赖性蛋白激酶(CaM-PK)抑制剂W-7对它们磷酸化的抑制作用要强得多。有趣的是,通过外源添加糖原合酶抑制剂氟化钠(NaF),在由玉米油、G-Rb1和G-Rb1加CCl4注射组制备的匀浆中,只有34 kDa的蛋白质发生了磷酸化。此外,G-Rb1在肝脏匀浆和微粒体中均抑制了CCl4诱导的Ca(2+)积累。上述结果表明,G-Rb1通过调节CaM-PK而非C激酶来抑制CCl4诱导的蛋白质磷酸化,并且34 kDa的蛋白质在细胞环境中可能发挥与118和63 kDa蛋白质不同的生物学作用。因此,一项将G-Rb1用作从Ca2+浓度紊乱到蛋白质磷酸化等关键CCl4诱导现象调节剂的研究,可能成功应用于探究肝脏的多种生理功能。